Electrical device containing an aryl sulfide dielectric liquid
    93.
    发明授权
    Electrical device containing an aryl sulfide dielectric liquid 失效
    含有芳基硫化物介电液体的电气装置

    公开(公告)号:US4343029A

    公开(公告)日:1982-08-03

    申请号:US187689

    申请日:1980-09-16

    IPC分类号: H01B3/20 H01B3/22 H01G4/04

    CPC分类号: C07C321/00 H01B3/20

    摘要: Capacitors and similar electrical devices containing a dielectric liquid have superior properties when the dielectric liquid is a polyalkylated diphenyl sulfide. Particularly good dielectric properties are provided when the liquid consists essentially of the mixed isomers obtained by reacting m-xylene or similar dialkylbenzene with SCl.sub.2.

    摘要翻译: 当电介质液体是多烷基化二苯硫醚时,含有介电液体的电容器和类似电气装置具有优异的性能。 当液体基本上由间二甲苯或类似二烷基苯与SCl 2反应获得的混合异构体组成时,提供特别好的介电性能。

    Novel 2,6-dinitrophenyl selenium compounds and their use as epoxidation
catalysts
    95.
    发明授权
    Novel 2,6-dinitrophenyl selenium compounds and their use as epoxidation catalysts 失效
    新型2,6-二硝基苯硒化合物及其作为环氧化催化剂的用途

    公开(公告)号:US4242285A

    公开(公告)日:1980-12-30

    申请号:US21272

    申请日:1979-03-16

    申请人: James M. Renga

    发明人: James M. Renga

    CPC分类号: C07C391/02 C07D301/12

    摘要: Novel unsubstituted and 4-substituted, 2,6-dinitrophenyl seleninic acids, selenium halides and diselenides are described. The above-described selenium compounds are particularly useful to catalyze the oxidation of olefins to the corresponding epoxide in the presence of hydrogen peroxide.

    摘要翻译: 描述了新的未取代和4-取代的2,6-二硝基苯基硒酸,硒化硒和二硒化物。 上述硒化合物特别可用于在过氧化氢存在下催化烯烃氧化成相应的环氧化物。

    Compounds and methods for controlling fungi
    96.
    发明授权
    Compounds and methods for controlling fungi 失效
    用于控制真菌的化合物和方法

    公开(公告)号:US08759356B2

    公开(公告)日:2014-06-24

    申请号:US12772248

    申请日:2010-05-03

    摘要: Various aspects disclosed herein relate to aryl substituted aminopyrimidines according to Formula 1: wherein, X1 is N or C—R3; X2 is N or C—R4 provided that X1 and X2 are not both N; R1-R7 are H, CN, CHO, —SCN, NO2, F, Cl, Br, I, substituted or unsubstituted C1-C4-alkyl, substituted or unsubstituted halo-C1-C4-alkyl, substituted or unsubstituted C1-C4-alkoxy, substituted or unsubstituted halo-C1-C4-alkoxy, substituted or unsubstituted C1-C4-thioalkyl, substituted or unsubstituted halo-C1-C4-thioalkyl, substituted or unsubstituted C3-C-7-cycloalkyl, substituted or unsubstituted C2-C4-alkenyl, C2-C4-alkynyl, substituted or unsubstituted C1-C4-acylalkyl, C1-C4-acyloxy, C1-C4 alkoxycarbonyl, C1-C4-alkoxy-amino, C1-C4-alkyl-S(O)═NH, substituted or unsubstituted aryl, substituted or unsubstituted heterocycle, wherein the substituents are one or more of the following F, Cl, Br, OH, CN, NO2, CHO, —SCN, S(O)n-C1-C4-alkyl (where n=0-2), C1-C4-alkyl, halo-C1-C4-alkyl, C1-C4-alkylamine, C1-C4-alkoxy, halo-C1-C4-alkoxy, C1-C4-thioalkyl, halo-C1-C4-thioalkyl, C1-C4-alkylacyl, C1-C4-acyloxy, C1-C4 alkoxycarbonyl, C1-C4-alkoxy-imino, hydroxy-imino; C1-C4-alkyl-S(O)═NH; and Q is a substituted or unsubstituted aryl, substituted or unsubstituted heterocycle wherein the substituents of Q are taken from R1-R7.

    摘要翻译: 本文公开的各个方面涉及式1的芳基取代的氨基嘧啶:其中,X 1是N或C-R 3; X2是N或C-R4,条件是X1和X2不同时为N; R 1 -R 7是H,CN,CHO,-SCN,NO 2,F,Cl,Br,I,取代或未取代的C 1 -C 4 - 烷基,取代或未取代的卤代-C 1 -C 4烷基,取代或未取代的C 1 -C 4 - 烷氧基,取代或未取代的卤代-C 1 -C 4 - 烷氧基,取代或未取代的C 1 -C 4 - 硫代烷基,取代或未取代的卤代-C 1 -C 4 - 硫代烷基,取代或未取代的C 3 -C 7 - 环烷基,取代或未取代的C 2 -C 4 烯基,C 2 -C 4 - 炔基,取代或未取代的C 1 -C 4酰基烷基,C 1 -C 4酰氧基,C 1 -C 4烷氧基羰基,C 1 -C 4烷氧基 - 氨基,C 1 -C 4烷基-S(O) 取代或未取代的芳基,取代或未取代的杂环,其中取代基是以下F,Cl,Br,OH,CN,NO 2,CHO,-SCN,S(O)n-C 1 -C 4烷基中的一种或多种 n = 0-2),C 1 -C 4 - 烷基,卤代-C 1 -C 4 - 烷基,C 1 -C 4烷基胺,C 1 -C 4 - 烷氧基,卤代-C 1 -C 4 - 烷氧基,C 1 -C 4 - C 1 -C 4烷氧基,C 1 -C 4烷氧基羰基,C 1 -C 4烷氧基亚氨基,羟基亚氨基, C 1 -C 4烷基-S(O)= NH; 并且Q是取代或未取代的芳基,取代或未取代的杂环,其中Q的取代基取自R 1 -R 7。

    COMPOUNDS AND METHODS FOR CONTROLLING FUNGI
    100.
    发明申请
    COMPOUNDS AND METHODS FOR CONTROLLING FUNGI 失效
    用于控制真菌的化合物和方法

    公开(公告)号:US20100298143A1

    公开(公告)日:2010-11-25

    申请号:US12772248

    申请日:2010-05-03

    摘要: Various aspects disclosed herein relate to aryl substituted aminopyrimidines according to Formula 1: wherein, X1 is N or C—R3; X2 is N or C—R4 provided that X1 and X2 are not both N; R1-R7 are H, CN, CHO, —SCN, NO2, F, Cl, Br, I, substituted or unsubstituted C1-C4-alkyl, substituted or unsubstituted halo-C1-C4-alkyl, substituted or unsubstituted C1-C4-alkoxy, substituted or unsubstituted halo-C1-C4-alkoxy, substituted or unsubstituted C1-C4-thioalkyl, substituted or unsubstituted halo-C1-C4-thioalkyl, substituted or unsubstituted C3-C-7-cycloalkyl, substituted or unsubstituted C2-C4-alkenyl, C2-C4-alkynyl, substituted or unsubstituted C1-C4-acylalkyl, C1-C4-acyloxy, C1-C4 alkoxycarbonyl, C1-C4-alkoxy-amino, C1-C4-alkyl-S(O)═NH, substituted or unsubstituted aryl, substituted or unsubstituted heterocycle, wherein the substituents are one or more of the following F, Cl, Br, OH, CN, NO2, CHO, —SCN, S(O)n-C1-C4-alkyl (where n=0-2), C1-C4-alkyl, halo-C1-C4-alkyl, C1-C4-alkylamine, C1-C4-alkoxy, halo-C1-C4-alkoxy, C1-C4-thioalkyl, halo-C1-C4-thioalkyl, C1-C4-alkylacyl, C1-C4-acyloxy, C1-C4 alkoxycarbonyl, C1-C4-alkoxy-imino, hydroxy-imino; C1-C4-alkyl-S(O)═NH; and Q is a substituted or unsubstituted aryl, substituted or unsubstituted heterocycle wherein the substituents of Q are taken from R1-R7

    摘要翻译: 本文公开的各个方面涉及式1的芳基取代的氨基嘧啶:其中,X 1是N或C-R 3; X2是N或C-R4,条件是X1和X2不同时为N; R 1 -R 7是H,CN,CHO,-SCN,NO 2,F,Cl,Br,I,取代或未取代的C 1 -C 4 - 烷基,取代或未取代的卤代-C 1 -C 4烷基,取代或未取代的C 1 -C 4 - 烷氧基,取代或未取代的卤代-C 1 -C 4 - 烷氧基,取代或未取代的C 1 -C 4 - 硫代烷基,取代或未取代的卤代-C 1 -C 4 - 硫代烷基,取代或未取代的C 3 -C 7 - 环烷基,取代或未取代的C 2 -C 4 烯基,C 2 -C 4 - 炔基,取代或未取代的C 1 -C 4酰基烷基,C 1 -C 4酰氧基,C 1 -C 4烷氧基羰基,C 1 -C 4烷氧基 - 氨基,C 1 -C 4烷基-S(O) 取代或未取代的芳基,取代或未取代的杂环,其中取代基是以下F,Cl,Br,OH,CN,NO 2,CHO,-SCN,S(O)n-C 1 -C 4烷基中的一种或多种 n = 0-2),C 1 -C 4 - 烷基,卤代-C 1 -C 4 - 烷基,C 1 -C 4烷基胺,C 1 -C 4 - 烷氧基,卤代-C 1 -C 4 - 烷氧基,C 1 -C 4 - C 1 -C 4烷氧基,C 1 -C 4烷氧基羰基,C 1 -C 4烷氧基亚氨基,羟基亚氨基, C 1 -C 4烷基-S(O)= NH; 并且Q是取代或未取代的芳基,取代或未取代的杂环,其中Q的取代基取自R 1 -R 7